Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Diabetes. Dec 15, 2024; 15(12): 2311-2321
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2311
Table 2 Range of motion examination, mean ± SD

Intervention (n = 42)
Control (n = 40)
P value
Ankle joint
D146.64 ± 11.747.9 ± 10.030.604
D1556.55 ± 11.6648 ± 9.99< 0.001
M649.4 ± 12.747 ± 9.250.332
D15-D19.9 ± 7.160.1 ± 3.26< 0.001
M6-D12.76 ± 7.26-0.9 ± 4.060.006
Subtalar joint
D121.43 ± 6.2223.13 ± 6.470.230
D1528.93 ± 4.4922.88 ± 6.29< 0.001
M625.4 ± 4.2823 ± 5.970.039
D15-D1 7.5 ± 5.12-0.25 ± 2.25< 0.001
M6-D13.98 ± 6.4-0.13 ± 3.49< 0.001
First metatarsophalangeal joint
D173.81 ± 17.0378.65 ± 19.520.234
D1583.88 ± 17.5180.63 ± 15.490.376
M675.55 ± 16.7777.5 ± 19.810.631
D15-D110.07 ± 18.661.98 ± 8.390.014
M6-D11.74 ± 19.72-1.15 ± 13.810.447